Efficacy and safety of different drug protocols for treating recent - onset atrial fibrillation  by Boriani, G. et al.
3~2A JACC F~hnmry Iq~),g 
definition of APVD and sllould be used when coth nnd/or TEE data are 
oqt,vocal, e~poctnlly m patients m whom corrective surgery is contemplated, 
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~[5~_ Safety and Praotlcallty of Magnetic Resonance 
Imsglng (MRI) for Non-lnvnlve Assessment of 
Coronary Stents 
S, Re,eniD, F De Cobolll, M, Tocchi, A, Anzuini, G, Re,anD, I, SIiolban, 
S, Cllierctli~, A, eel Ms,ohio, U, TM, EJ,, O~llvo~ton, TX, USA; H..~. R ,  MilAn, 
/tmy 
Backgmtrnd: Coronary .fonts. o~pectnlly stainless stool steals, nm barely 
visible by co.It.st nngiography nr fluoroscopy, MRI, whictl allows obfaining 
nonlnvastve coronary anglo, rams, OOtlld be rise|ill fo Iocalttn ,fonts and 
verily their pafenoy, However, pedermancn of MRI early niter .tenting may 
rams concern ~bout possible metal pro,ill.sOs di~ledgnm~nf dl, le to tile hlgll 
magnetic field sfrongth, 
M#thlxt~: We sfudlnd fg pt. with 30 steals (13 Pnlmaf;t.~cbaf.-, 10 Multi. 
Link, 7 NIIR)in 23 vns.els 111 LAID, g RCA, 3 LCx) MRI was padatmed wlfh 
a 1,5.T imagor at 2 dny~ (5 pt.) or (~ monflls (14 pfs) Imm slanting Cemmtry 
imagos worn obtained lining bmntll.lloldlng EC(3.gnted segmented k.spaco 
fl'~st gradient.eerie sequence, wltll and wlllleul lat.mlppmsslon (F~) 
Ro~I#~: NO pf showed advemo nvenl, dnflng Or after MRI. Imaging tnmo 
WaS ~A t f2 mlnl On MRI wlttlmll FS, all ,font. warn clearly visualized 
aS .rot'Is Of signal void, whelsl'l~ cOrOllary ~nglllOt'~l~ ptoximi~l ~nd distal 
to fhn sfnnf were tinnily s~en M~asut{~menfs el fl~e length el II~o~ latgm 
signal VOld in plnnes nn~nted along fbfi lOn~l,a~IS of steal well correlated 
wlfb lhoso el tho Oxpnnd~d steal 11 ~ 0,07, p 1 0'01) 1 FS piffles definitely 
Improved the high .Ignal Intonsily IIil0ai strucfltro of flow, and steals worn 
indirectly Imaged as ama~ el tlow intorrupflon .troller fo fllOSO gonolafod by 
long native atone.o. Sfonf patent:y, Inferred by vlStlallzafton el Ilow distal 
to the dnvlco, was defected In 17 pts and conhimed by anglegraphy in all 
crises, bill In-slnnf rostenosls .50% ','~ffq present m 2' pts Sfonl occlusion 
won cormclly din,nosed In 3 pnflonfs by the absence of dmlN flew on MRI 
Concluston.~, This study Is fl~o Ilmf to domonsfrafo fhffl MRI can be saloly 
podormod ~s early as ~ days alter ,tenting, nnd ylold.~ 1ollabte intom~aflon 
on sfonf leo.flea and patoncy, whtcl~ may be partlcuhlrly relevant II slant 
d~splneomonf or occltt~lan ~o suspected 
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 atmo., E,.0, of  y.d.ome x .at,o.,s w,,. 
Doxazoalne as Assessed by Positron Emission 
Tomography  
H,-MJ, Siobohnk, J,G Moodor, P,K Blanksma, A,J Van Bovon, 
R,L. At'~thomo, W Witting, W Vaalburg~ H. JGM Cvlins. University Hosptl~rl 
GrOIltI)~(3II, Th¢3 N~>lhl)r , nd,~ 
Bac,~gtotmd, The fundamental abnormahty in syndrome ~ ~angina pectons, 
mchemla-like stress ECG dosplfo normal coronary art~ues) might be a 
patchily distnbuled increased vasoconsfnctor t0ne of fh5 coronary micro- 
cirultlalion. Since ;t has boon suggested that sympalhefic onlrol of coronary 
micmvessel tone is mediated ,~ receptors, the inlluonco of tl~o ,~-1 adronocep- 
for antagonist doxnzoslno on coronary vasomotion in patients w~th syndrome 
X was ovattlatod. 
MethocL~. Porametnc 13-N ammoma Posif[on Emission Tomoglaphy (PET) 
was used to assess myocardial pedusion, coronary vascular resistance 
(CVR; mean arterial pressure!myocardial podusion) and coefficient of van- 
alien (CV; an indication of perlusion heterogeneily) at rest and =n response 
to aufonomic slimulaficn with cold presser test (CPT). Eleven syndrome X 
patients (moan age 57. 3 men. not responding to t ~ blocker and calcinm 
antagonist) were sfudiod at basohne and on treatment with doxazosine (up- 
titrated to 4 mg dmly) 
Results (Mean t SD): 
Ba~lmD Doxatoslno 
Rest CPT ratio Rest CPT ratio 
Parr,as=oil 131 ~ 18 134 t 22 103 ~ 001 127 ! 24 156 ~ 29" 124 ! 020' 
(ml/n'.n/100 m]) 
CVR 073~:01 083t02  114 ~001 0,75 t 02 071 ,.02" 0941018 = 
tmmHg/mVmin[ 100 ml) 
CV 141 +-22 176136 126~027 144~27 15513;. 1091012 
• p . 0.01. '~ p 0.03. p - 006conlpm~dlo basehno. 
Dunng CPT, treatment with doxazosine increases pedusion, reverses 
CVR from increase to decrease and shows a trend to a more homogeneous 
per'fusion (CV). Anginal complaints improved in 8 patients. 
Conclusion: The (~-1 adrenoceptor antagonist doxazosine seems to atten- 
uate coronary hyperreactwily of coronary microvessels and to reduce angina 
pectons in patients with syndrome X. 
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~ Effl©acy of Different Protocols for end Safety Drug 
~ast lng  Recent  - Oneet  Atrial  F lbr l l let!on 
G, Boriani, M, Biffi, A, Captloci, G, Bolto, M, Onoas, G Tnsollno, L Rubino, 
El, MagnanL #tsfftut~ el C~]rdlology, Univ of Oolegn,'l ¢lnd AF Shtc~, Grorrp~ 
Italy 
In a patient pop~llallon of 417 pallentsi (pts) fhe efficacy and safety ot dilfemnt 
thorapeufic sfatogios for convoding intent,onset algal fibnllaf!on (AFt ( -7  
days) to sinus lbyfhm (SR) wore analysed. All fhe pfs were in NYHA class 
2, wlfbeuf signs Or symptoms of heart Is!lure and were hospttalised. Th~ 
pfs worn landemly allot.fed fo treafmenf with one el !he following dl;~JS: 
tV staled.rune ( Iv AM) 15 mg~Kg as bolus, then 1 8 grf94 hours) 151 pts), 
I v propfd0nene (I.v PF) (2 ms/Ks .rs boll0., then 000;'8 mg~Kg~mm) ,,57 pts), 
oral loading with ptopafoeono Ioral PF) t600 mg po  as single dose) 1119 
pfn) and o1~tl Io~d,lg w=th Ilecami~o (oral FL) (300 mg p o. as smgto dose) 
(69 pls) All the pls were submiffod lo Holier monltonng and co.veto=on, lo 
SR wore evakt~lod al 1, 3 and 8 houm 
Results In the following labia convelalon {ales to SR and se~lo  a~rso  
DireCtS (low oUfpl.!f, loll vontncular msulllcloncy of at.at flutter wrth 11 AV 
conduct~onl am reported fo~ oven/I~oatmenl: 
PLA u v &M I v PF oval PF real FL 
SR 1 his 11 t.q%) 316%1 22139%1 1018%)  9113%1 
SFI 3 ttlb ~.~0 t t 6%1 t 3 t~5%t 33 taS%)" 5,4 t45%i" 39 t~':'~l - 
SR " S v~l~ 4f~ 137%1 2S t57"~1 ~ 43175%1" St 176%)" .~2 i75"~=)" 
Adv E" tnl 1 0 1 O 4 
Lt.~tlond ' p 0 01 v,~ PLA p O 0[~ v.~ PLA. Ad~, oll = ('Kl~el'~e efte~l~ 
In Conc/usfon 1) I v. AM ts not effecbve al short toms in this population 
2) iv  PF is more effective within I hour comp:lred to oral loading with PF 
or FL. bur w{lhout ditlo[ont olhcac=os at 3 and 8 hours; 3) the evaluation el 
placebo ettecl is mandalory 
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8~93--~ 1 Is Ibutl l ide a Negat ive Inotrope for  the Left  Atr ia l  
. . . . .  Appendage?  
L earuch. J Banker Bronx VA t~d~cal Center. Cardrovascular Institute. Mt 
Sirras Sct~.~.~J et It,ted.:.~e. N~ NY USA 
Left at.at appendageal (LAA) dysfuncbon alter card,overseen "stunning ° ~s 
manifested by a reduction in LAA velecdles and increase ~n smoke IS+) The 
elfect el anbarrhythmic agents on LAA Innction in the absence of card,over- 
seen (CV) is unknown TEE was pedormed during the inlusion el up to 2 mg 
el ibuhhde (a class III agent) in 14 patients with at.el librillation in = 4) or 
flutter (n = 10) pnor to CV. We assessed 1) LAA emptying tLAE) velocmes. 2) 
LAA filling (LAF) velocities, and 3) increase in smoke IS+) alter each 0.2 mg 
of ibublide and alter conversion to sinus rhythm (RSR). 5 patients converted 
to RSR wdh ;buhhdo (mean I mg). while 8 of 9 pal;eats converted electecally 
tmean 107 Joules). 
~ L&A Ihn 9 i 
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Ibutllldl doll (fftg. t
Independent of the method of CV, LAE decreased lrom 398 to 25 cm/sec 
(p 0.003) and LAF decreased from 47.7 to 31.7 cmtsec (p - 0.003) post 
CV. No pauent in fhe absence of conversion to RSR had S+, while 9 of 13 
Ilad S+ after successlut cardioversion. 
Conclusion: Incremental doses of ibutilide do not cause atdal stunning 
and may improve LAA function. Appendageal stunning with ibufilide occurs 
only with restoration of sinus rhythm. 
